Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
01/27/1993 | EP0524639A2 Process for the labelling of substances with technetium or rhenium |
01/27/1993 | EP0524584A2 Method for the preparation of high-affinity hapten-specific antibodies and a composition for the detection of haptens |
01/27/1993 | EP0524553A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
01/27/1993 | EP0348442B1 Altered antibody |
01/27/1993 | CA2074590A1 Process for the production of high affinity anti-hapten antibodies and composition for the determination of haptens |
01/26/1993 | US5182366 Simplified method of forming identifiable sequences of amino acids |
01/26/1993 | US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
01/26/1993 | US5182113 Factor xa inibitor from leech and pharmaceutical compositions containing same |
01/23/1993 | WO1993002211A1 Method of stabilizing proteins during optical tests |
01/23/1993 | CA2092098A1 Process for the stabilization of proteins in optical tests |
01/21/1993 | WO1993001484A1 A method to identify protein sequences that fold into a known three-dimensional structure |
01/21/1993 | WO1993001241A1 Use of unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, and collagen and biomaterial thereby obtained |
01/21/1993 | WO1993001208A1 2-[3-(4-amidinophenyl)]propionic acid derivatives, their preparation and their use |
01/21/1993 | WO1993001207A1 Process for the purification of serum albumin |
01/21/1993 | WO1993001206A1 Conformationally restricted biologically active peptides, methods for their production and uses thereof |
01/21/1993 | WO1993001167A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
01/21/1993 | WO1993000923A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
01/21/1993 | WO1993000807A1 Method for stabilization of biomaterials |
01/21/1993 | CA2113190A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
01/21/1993 | CA2112580A1 2-substituted 3-(4-amidinophenyl) propionic acid derivatives, the preparation and use thereof |
01/20/1993 | EP0523982A1 Low-viscosity polymer solution for capillary electrophoresis |
01/20/1993 | EP0523461A2 Process for the saponification of aminoacid-/peptide ester |
01/20/1993 | EP0523449A2 Reductive amination of an aminoacid or an aminoacid derivative with an alpha-keto acid or an alpha-keto acid derivative |
01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
01/20/1993 | EP0523296A1 An improved method for folding tissue plasminogen activators and derivatives thereof |
01/19/1993 | US5180816 Fab fragments, sulfhydryl containing coupler, thioester |
01/19/1993 | US5180815 Modified protein for carrying hapten |
01/19/1993 | US5180811 Proteins having a tnf action comprising tnf-fibromectin fusion protein |
01/19/1993 | US5180807 C-terminal peptide or protein sequencing reagent and method |
01/19/1993 | US5180678 Uses of substantially pure interleukin-9 receptor |
01/19/1993 | US5180668 Hirudin derivative |
01/19/1993 | CA1312995C Method for producing indan derivatives |
01/19/1993 | CA1312994C2 Protein purification |
01/19/1993 | CA1312991C Solid supports for peptide synthesis |
01/16/1993 | CA2073818A1 Transesterification and other conversion reactions of acid derivatives, using an amidine |
01/16/1993 | CA2047063A1 Method for folding tissue plasminogen activators and erivatives thereof |
01/14/1993 | DE4122846A1 Controlling specificity of liq.-solid heterogeneous process - using non-diffusion limited solid matrix, by varying contact time, etc., e.g. for sepn. of albumin from immunoglobulin |
01/14/1993 | DE4121753A1 Purificn. of peptide derivs. by chromatography on hydrophobic carrier - uses acidic eluent so that lipophilic impurities are retained but target cpd. is not and providing high yield at high column loadings |
01/13/1993 | EP0522560A2 Method and composition for the prevention of Lyme disease |
01/13/1993 | EP0522203A1 Protein from lactic acid bacteria |
01/13/1993 | EP0522086A1 DNA SEQUENCE ENCODING GALACTOPROTEIN b3. |
01/13/1993 | EP0522073A1 Improved major histocompatibility complex (mhc) molecules |
01/13/1993 | EP0521996A1 Catalytic antibody components |
01/13/1993 | EP0521911A1 Method and device for moving molecules by the application of a plurality of electrical fields |
01/12/1993 | US5179199 Ion exchanging, washing with an aqueous solvent and elution |
01/12/1993 | US5179197 Removing transferrins and peroxidase from milk or whey by chromatography, desalting, absorption by ion exchange resin, elution |
01/12/1993 | US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes |
01/12/1993 | CA1312702C Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use |
01/07/1993 | WO1993000625A1 Computer-controlled, module type, multipurpose synthesizer |
01/07/1993 | WO1993000365A2 Hepatitis c virus (hcv) polypeptides |
01/07/1993 | WO1993000363A1 Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
01/07/1993 | WO1993000355A1 Protein sequencing |
01/07/1993 | WO1993000107A1 Therapeutic fragments of von willebrand factor |
01/07/1993 | WO1993000105A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
01/07/1993 | WO1993000049A1 Osteogenic factor |
01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
01/07/1993 | EP0483162A4 Sequential c-terminal degradation of peptides and proteins |
01/07/1993 | DE4209215A1 Hcv peptidantigene und verfahren zur bestimmung von hcv HCV peptide antigens, and methods for the determination of HCV |
01/07/1993 | DE4121947A1 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung 2- (3- (4-amidino-phenyl)) - propionic acid derivatives, their preparation and use |
01/07/1993 | CA2112226A1 Purification of recombinant apolipoprotein e from bacteria |
01/07/1993 | CA2111870A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
01/07/1993 | CA2093790A1 Osteogenic factor |
01/06/1993 | CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content |
01/05/1993 | WO1993001210A2 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) |
01/05/1993 | US5177194 Process for purifying immune serum globulins |
01/05/1993 | CA2089576A1 Hcv peptide antigens and methods for the determination of hcv |
01/02/1993 | CA2072824A1 Cluster conjugates of drugs with antibodies |
12/30/1992 | EP0520748A1 Storage of materials |
12/30/1992 | EP0520573A1 Cyclic imide derivatives |
12/30/1992 | EP0520502A2 Anti-Hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
12/30/1992 | EP0519986A1 Synthetic polypeptides |
12/30/1992 | EP0519953A1 Acyl phosphate esters and modification of proteins therewith. |
12/30/1992 | EP0208785B1 Fibrinophilic urokinase complex and process for its preparation |
12/30/1992 | CA2072725A1 Glycopeptides, a process for their preparation and their use |
12/29/1992 | US5175254 Solid phase peptide synthesis using a polyacrylic support in aqueous solution |
12/29/1992 | US5175146 Synthetic calcitonin peptides |
12/29/1992 | US5175105 Process for the production of urokinase using saccharomyes cerevisiae |
12/29/1992 | US5175096 Dna encoding a fibronectin binding protein as well as its preparation |
12/28/1992 | CA2072551A1 Cyclic imide derivatives |
12/23/1992 | WO1992022875A1 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) |
12/23/1992 | WO1992022646A1 Production of human hemoglobin in transgenic pigs |
12/23/1992 | WO1992022644A1 Production of a protein of interest in the milk of a transgenic mammelian |
12/23/1992 | WO1992022591A1 Polymeric resin for peptide synthesis |
12/23/1992 | WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins |
12/23/1992 | WO1992022569A1 Peptides with tachykinin antagonist activity |
12/23/1992 | WO1992022566A1 Protected amino-acid unit, its preparation and its use |
12/23/1992 | WO1992022324A1 Microbially-produced antibody fragments and their conjugates |
12/23/1992 | WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF |
12/23/1992 | WO1992022318A1 Amino acid derivative and bromoacetyl modified peptides |
12/23/1992 | WO1992015605A3 Inhibitors of human neutrophil elastase and human cathepsin g |
12/23/1992 | EP0519903A1 Drug containing activated protein C |
12/23/1992 | EP0519889A2 Leydig cell stimulator |
12/23/1992 | EP0519726A2 A process for large-scale production of antimicrobial peptide in high purity |
12/23/1992 | EP0519640A1 Rapid synthesis and screening of peptide mimetics |
12/23/1992 | EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides |
12/23/1992 | EP0519327A1 N-Acyl-S-(2-hydroxyalkyl)-cysteines, their preparation and their use as intermediates in the preparation of synthetic immunoadjuvants and synthetic vaccines |
12/23/1992 | EP0519203A2 Apparatus and method for electrophoretic separation of proteins |
12/23/1992 | EP0519039A1 HUMAN bFGF DERIVATIVES, THEIR ANALOGS AND PROCESS FOR THEIR PRODUCTION |
12/23/1992 | EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
12/23/1992 | EP0518982A1 Method for enhancing antibody transport through capillary barriers |